• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Cord Blood America CEO Matthew Schissler Interviewed on 'Your Cancer Today' TV Show

Posted on: Thursday, 17 May 2007, 06:00 CDT

LOS ANGELES, May 17 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/) which is focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that CEO Matthew Schissler will appear on the "Your Cancer Today(TM)" show discussing umbilical cord blood stem cell collection and its enormous impact on the treatment of certain cancers.

The show will be available for viewing at the Internet web site at http://www.yourcancertoday.com/ starting 3 p.m. Eastern on Thursday, May 17. The show will be available to global TV viewers beginning shortly afterwards. A schedule on when the new, half-hour TV show, which is dedicated to inform and educate viewers on various cancer treatments and the research being conducted into this disease, is available at the Your Cancer Today web site.

"The fact that umbilical cord blood storage is being discussed on this important program shows the progress that is being made in the treatment of various cancers by stem cells that are saved at birth," Mr. Schissler said. "The more people understand the enormous potential of stem cells to launch a new era in medicine, the more they will understand the business model and strategies we have developed at Cord Blood America."

About Cord Blood America

Cord Blood America (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate,""believe,""expect,""future,""intend,""plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com

Cord Blood America, Inc.

CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365,pknopick@eandecommunications.com, for Cord Blood America, Inc.

Web site: http://www.yourcancertoday.com/

Web site: http://www.corcell.com/

Web site: http://www.cordblood-america.com/

Source: PRNewswire-FirstCall

More News in this Category